Minicircle DNA Vectors for Site-Specific Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for introducing exogenous DNA into cells for long-term protein expression are limited by the inefficiencies of homologous recombination and the drawbacks of viral vectors, such as immunogenicity and integration-mediated mutation problems.
Innovation Solution
Development of minicircle nucleic acid vectors that are free of plasmid backbone DNA sequences and contain a unidirectional site-specific recombinase, allowing for site-specific integration and expression of exogenous sequences without genome integration, using a system that includes genetically modified bacteria to produce vectors with reduced contaminating nucleic acid sequences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors are used to introduce exogenous DNA into cells for long-term expression, then transformation efficiency and genome integration capability are improved, but immunogenicity and integration-mediated mutation problems worsen
Solution Approach 1:
The invention extracts and removes the plasmid backbone sequences from the vector construct, retaining only the essential expression cassette and homology regions. This creates a minicircle vector that eliminates immunogenic elements while preserving transformation capability, directly addressing the harmful effects of viral and plasmid vectors
Solution Approach 2:
The minicircle vector is designed as a transient, non-integrating delivery vehicle that performs its function and is then naturally degraded. This disposable approach avoids the long-term persistence and immunogenicity problems of viral vectors, while still achieving efficient transient or stable expression through homology-directed repair
2Duration of action of stationary object
If homologous recombination based protocols are used for genome integration, then stable long-term expression is achieved, but recombination speed and efficiency worsen
Solution Approach 1:
The invention changes the physical parameters of the vector by reducing its size to a minicircle configuration and optimizing the homology region lengths. This size optimization enables faster cellular uptake and more efficient homology-directed repair, accelerating the integration process while maintaining stable long-term expression
3Stability of the object's composition
If plasmid backbone sequences are included in the vector, then vector stability and replication capability are improved, but contamination with unwanted nucleic acid sequences worsens
Solution Approach 1:
The invention extracts and removes the plasmid backbone sequences (origin of replication, antibiotic resistance genes, etc.) from the vector construct, retaining only the essential expression cassette flanked by homology regions. This eliminates contaminating nucleic acid sequences that could cause unwanted effects while maintaining vector function through homology-directed integration
Solution Approach 2:
The invention converts the potential harm of backbone sequences (immunogenicity, contamination) into a benefit by using the minimal necessary elements. The small size and simplicity of the minicircle actually enhance its utility as a delivery vehicle, as it is more efficiently taken up by cells and processed by homology-directed repair mechanisms
4Productivity
If high amounts of L-arabinose are used to induce DNA editing enzymes, then enzyme expression and minicircle production are improved, but manufacturing cost worsens
Solution Approach 1:
The invention changes the induction parameter by optimizing the L-arabinose concentration and induction timing. The minicircle production system uses controlled induction at specific growth phases, reducing the total amount of L-arabinose required while maintaining high enzyme expression levels and production efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The minicircle vectors enable persistent and efficient protein expression in cells, reducing the risk of genomic damage and improving the stability of genetic modifications, while minimizing the use of L-arabinose and simplifying vector construction and purification.
Implementation Method 1
contacting the parental plasmid with a unidirectional site-specific recombinase under conditions that allow the recombinase to mediate site-specific recombination between an attB sequence and an attP sequence, thereby generating a minicircle vector
Implementation Method 2
contacting the parental plasmid with a restriction endonuclease under conditions that allow the restriction endonuclease to cleave the parental plasmid at a restriction site
Implementation Method 3
transfecting a bacterial cell with a parental plasmid, wherein the bacterial cell synthesizes a copy of the parental plasmid
Data Source
AI summary
The present invention provides minicircle nucleic acid vector formulations for use in administering to a subject, wherein the minicircle nucleic acid vectors include a polynucleotide of interest, a product hybrid sequence of a unidirectional site-specific recombinase, and are devoid of plasmid backbone bacterial DNA sequences. Also provided are methods of producing the subject formulations as well as methods for administering the minicircle nucleic acid vector formulations to a subject. The subject methods and compositions find use in a variety of different applications, including both research and therapeutic applications.